Eligible, commercially insured patients
may pay as little as*:
This site is intended only for healthcare professionals.
For support, call 1-833-956-DERM (1-833-956-3376)
Monday-Friday, 8 AM-8 PM ET
Eligible, commercially insured patients
may pay as little as*:
Eligibility required. No membership fees. This is not health insurance. For CIBINQO, the maximum benefit per patient is $4,000-$15,000 per calendar year. For LITFULO, the maximum benefit per patient is $4,000-$15,000 per calendar year. For EUCRISA, individual savings limited to $970 per tube or $3,880 in maximum total savings per calendar year. Only for use with commercial insurance. If you are enrolled in a state or federally funded prescription insurance program, you may not use the copay card. Terms and conditions apply.
Download a Copay Savings Card at:
If a delay or coverage denial occurs during the prior authorization or appeals process, eligible, commercially insured patients enrolled in Pfizer Dermatology Patient Access may receive CIBINQO or LITFULO for up to 2 years at no cost, shipped to them through Interim Care Rx.†
If a patient has coverage under Medicare, Veterans Affairs, TRICARE®, or Medicaid, the Pfizer Dermatology Patient Access team will guide them about where they may find financial assistance:
If patients who have government insurance need financial assistance, we’ll check their eligibility for Medicare Part D Low-Income Subsidy (Extra Help). If a patient appears to be eligible based on income, we can help them understand how to apply.
If patients are turned down for Medicare Extra Help, they will be evaluated for eligibility in the Pfizer Patient Assistance Program.
For patients who have no insurance, the Pfizer Dermatology Patient Access team can help identify potential resources for coverage:
We will check to see if your patients may be eligible for Medicaid and, if so, explain how they can contact Medicaid to apply.
If eligible, government underinsured or uninsured patients may be eligible for free medicine through the Pfizer Patient Assistance Program. Patients must meet the eligibility requirements and reapply as needed.